How Zimmer Biomet, Stryker, Smith+Nephew compare in Q3

Zimmer Biomet, Stryker and Smith+Nephew all recently reported their third quarter results. While Smith+Nephew and Zimmer Biomet saw dips in orthopedic performance, Stryker saw revenue gains.

Advertisement

Here’s a comparison of their performances:

Zimmer Biomet
Total sales: $1.9 billion
U.S. hip sales: $244.2 million
U.S. knee sales: $386.3 million
Spine and dental sales: $238.6 million

Stryker
Total sales: $4.2 billion
Hip sales: $328 million
Knee sales $439 million
Neurotechnology and spine sales: $876 million

Smith+Nephew
Total sales: $1.3 billion
Hip sales: $145 million
Knee sales: $207 million
Orthopedic sales: $508 million

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.